Evgen Pharma plc to hold an Investor Symposium titled “The clinical significance of SFX-01”

Evgen Pharma plc (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, have today announced that it is to hold an Investor Symposium for investors and analysts on the morning of Tuesday 18 September 2018.

The Investor Symposium, titled “The clinical significance of SFX-01”, will be an opportunity to engage with the Company and independent experts to help frame the significance of the two Phase II clinical read-outs of SFX-01 expected around the end of the year.

The morning will feature a short introduction by Evgen’s CEO, Stephen Franklin, followed by a series of presentations and a Q&A session. The presentations will include:

• Vadim Alexandre – Managing Director, Northland Capital Partners
The biotech investment market and Evgen Pharma plc

• Prof Albena Dinkova-Kostova – University of Dundee
The science behind sulforaphane

• Dr Sasha Howell – The Christie Hospital, Manchester
The STEM trial in breast cancer

• Sally Ross – Clinical Development Officer, Evgen
The SAS trial in haemorrhagic stroke and the preclinical pipeline

The event will be held at the offices of Buchanan, 107 Cheapside, London EC2V 6DN and will begin at 9.15am. The presentations will be available on the Evgen Pharma plc website on the day. No new material trading information will be disclosed.

Those interested in attending the event, can register with Buchanan on 020 7466 5000 or email tillya@buchanan.uk.com

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    X
    LinkedIn
    Evgen Pharma Plc

    More articles like this

    Evgen Pharma Plc

    21 Health Benefits of Broccoli

    Are you looking for a vegetable to spice up your diet in a healthy way? If yes, then broccoli, also called Brassica oleracea italica, is the vegetable you want. The dark green crucifer is not only

    Evgen Pharma Plc

    12 things that are actually tied to breast cancer

    According to the Centres for Disease Control and Prevention (CDC), breast cancer is the most common cancer in women. In the US, one in eight women will develop breast cancer during her lifetime. Those statistics sound

    Evgen Pharma Plc

    10 subtle signs of breast cancer

    A diagnosis of breast cancer can be terrifying. According to the CDC, Breast cancer is the most common cancer in American women of any race or ethnicity. Though the statistics might be scary, catching breast cancer

    Evgen Pharma Plc

    Evgen Pharma plc Investor Presentation in Manchester

    Evgen Pharma plc (LON: EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, announces that Steve Franklin, the Company’s CEO, will be presenting tomorrow evening at a ShareSoc Growth

    Evgen Pharma Plc

    ‘I never knew men could get breast cancer’

    Moses Musonga never thought men could get breast cancer until he was diagnosed with the disease in 2013. The 67-year-old Kenyan told the BBC that he was profoundly shock when doctors told him in 2013 that

    Evgen Pharma Plc

    Male Breast cancer:What are the signs and how to check?

    Breast cancer is more commonly associated with women more than with men, affecting approximately one in eight women in their lifetimes. However, men can still be diagnosed with breast cancer, albeit in far rarer circumstances. While